System and method of treating stuttering by neuromodulation

• US 6,944,497 B2
• Filed: 10/31/2001
• Issued: 09/13/2005
• Est. Priority Date: 10/31/2001
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Stypulkowski, Paul H.
• Primary Examiner(s): Schaetzle, Kennedy
• Assistant Examiner(s): DROESCH, KRISTEN L
• Application Number:
  US10/001,751
• Publication Number:
  US 20030082507A1
• Time in Patent Office: 1,413 Days
• Field of Search: 607 1- 2, 607/48, 607115-116, 607/118, 128897-898
• US Class Current: 607/2
• CPC Class Codes: A61F 5/58 Apparatus for correcting stammering or stuttering
• CPC Class Codes: A61M 2210/0693 Brain, cerebrum
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: A61N 1/32 alternating or intermittent currents applying electric fields by inductive or capacitive coupling A61N1/40; microwave apparatus A61N5/02

Abstract

Stuttering-treatment techniques using neural stimulation and/or drug delivery. One or more electrodes and/or a catheter are implanted adjacent to sites in the brain. A signal generator and the electrode deliver stimulation to a first site. A pump and the catheter deliver one or more therapeutic drugs to a second site. The first and second sites could be: the supplementary motor area, the centromedian circuit, the dorsomedial nuclei, the lateral prefrontal circuit, or other paramedian thalamic and midbrain nuclei. The stuttering treatment could be performed via periodic transcranial magnetic stimulation. A sensor, located near the patient'"'"'s vocal folds, can be used for generating a signal responsive to activity of the patient'"'"'s speech-producing muscles. A controller adjusts one or more stimulation parameters in response to the signal from the sensor.

Claims

1. A system for therapeutically treating stuttering in a patient comprising:

a signal generator;

at least one implantable lead, coupled to the signal generator, for delivering electrical stimulation to at least one predetermined site of the patient'"'"'s brain;

a sensor, located near the patient'"'"'s vocal folds, for generating a signal responsive to activity of the patient'"'"'s speech-producing muscles;

a controller that performs speech-recognition processing on the signal from the sensor to detect stuttering and that adjusts at least one stimulation parameter in response to detecting stuttering.

2. The system of claim 1, wherein the controller detects when the patient starts speaking and starts the electrical stimulation in response to detecting that the patient has started to speak.

3. The system of claim 2, wherein the controller stops the electrical stimulation a predetermined amount of time after the patient has started to speak.

4. The system of claim 1, wherein the sensor is an electromyographic sensor.

5. The system of claim 1, wherein the sensor is an electroglottographic sensor.

6. The system of claim 1, wherein the sensor is a microphone.

7. The system of claim 6, wherein the microphone is human-implantable.

8. The system of claim 1, wherein:

the speech-recognition processing detects stuttering by detecting a predetermined number of repetitions of a speech pattern.

9. A system for therapeutically treating stuttering in a patient comprising:

signal generator means for generating a signal;

implantable lead means, coupled to the signal generator, for delivering electrical stimulation to at least one predetermined site of the patient'"'"'s brain;

sensor means, located near the patient'"'"'s vocal folds, for generating a signal responsive to activity of the patient'"'"'s speech-producing muscles;

controller means for performing speech-recognition processing on the signal from the sensor means to detect stuttering and for adjusting at least one stimulation parameter in response to detecting stuttering.

10. The system of claim 9, wherein the controller means detects when the patient starts speaking and starts the electrical stimulation in response to detecting that the patient has started to speak.

11. The system of claim 9, wherein the controller means stops the electrical stimulation a predetermined amount of time after the patient has started to speak.

12. The system of claim 9, wherein the sensor means comprises:

an electromyographic sensor.

13. The system of claim 9, wherein the sensor means comprises:

an electroglottographic sensor.

14. The system of claim 9, wherein the sensor means comprises:

a microphone.

15. The system of claim 9, wherein the microphone is human-implantable.

16. The system of claim 9, wherein:

the speech-recognition processing detects stuttering by detecting a predetermined number of repetitions of a speech pattern.